146 related articles for article (PubMed ID: 21050999)
21. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
Mohan G; Chattopadhyay S
JAMA Oncol; 2020 Sep; 6(9):1434-1444. PubMed ID: 32556187
[TBL] [Abstract][Full Text] [Related]
22. Coverage for cancer treatment extended to poor women in US.
Josefson D
BMJ; 2000 May; 320(7246):1360. PubMed ID: 10818017
[No Abstract] [Full Text] [Related]
23. Association of Medicaid enrollee characteristics and primary care utilization with cancer outcomes for the period spanning Medicaid expansion in New Jersey.
Tsui J; DeLia D; Stroup AM; Nova J; Kulkarni A; Ferrante JM; Cantor JC
Cancer; 2019 Apr; 125(8):1330-1340. PubMed ID: 30561793
[TBL] [Abstract][Full Text] [Related]
24. Increased Cancer Screening for Low-income Adults Under the Affordable Care Act Medicaid Expansion.
Hendryx M; Luo J
Med Care; 2018 Nov; 56(11):944-949. PubMed ID: 30199428
[TBL] [Abstract][Full Text] [Related]
25. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
[TBL] [Abstract][Full Text] [Related]
26. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.
Mandelblatt JS; Lawrence WF; Gaffikin L; Limpahayom KK; Lumbiganon P; Warakamin S; King J; Yi B; Ringers P; Blumenthal PD
J Natl Cancer Inst; 2002 Oct; 94(19):1469-83. PubMed ID: 12359856
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Utilization, Costs, and Quality of Medicaid vs Subsidized Private Health Insurance for Low-Income Adults.
Allen H; Gordon SH; Lee D; Bhanja A; Sommers BD
JAMA Netw Open; 2021 Jan; 4(1):e2032669. PubMed ID: 33399859
[TBL] [Abstract][Full Text] [Related]
28. Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa.
Lince-Deroche N; Phiri J; Michelow P; Smith JS; Firnhaber C
PLoS One; 2015; 10(11):e0141969. PubMed ID: 26569487
[TBL] [Abstract][Full Text] [Related]
29. The effect of delivery structure on costs, screening and health promotional services in state level National Breast and Cervical Cancer Early Detection Programs.
Trogdon JG; Ekwueme DU; Subramanian S; Miller JW; Wong FL
Cancer Causes Control; 2019 Aug; 30(8):813-818. PubMed ID: 31187351
[TBL] [Abstract][Full Text] [Related]
30. Cost of services provided by the National Breast and Cervical Cancer Early Detection Program.
Ekwueme DU; Subramanian S; Trogdon JG; Miller JW; Royalty JE; Li C; Guy GP; Crouse W; Thompson H; Gardner JG
Cancer; 2014 Aug; 120 Suppl 16(Suppl 16):2604-11. PubMed ID: 25099904
[TBL] [Abstract][Full Text] [Related]
31. Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa.
Vijayaraghavan A; Efrusy M; Lindeque G; Dreyer G; Santas C
Gynecol Oncol; 2009 Feb; 112(2):377-83. PubMed ID: 19081611
[TBL] [Abstract][Full Text] [Related]
32. From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program.
Miller JW; Hanson V; Johnson GD; Royalty JE; Richardson LC
Cancer; 2014 Aug; 120 Suppl 16(0 16):2549-56. PubMed ID: 25099897
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness analysis of cervical cancer screening strategies based on the Papanicolaou smear test in Korea.
Ko MJ; Kim J; Kim Y; Lee YJ; Hong SR; Lee JK
Asian Pac J Cancer Prev; 2015; 16(6):2317-22. PubMed ID: 25824757
[TBL] [Abstract][Full Text] [Related]
34. Prevalence, healthcare utilization, and costs of breast cancer in a state Medicaid fee-for-service program.
Khanna R; Madhavan SS; Bhanegaonkar A; Remick SC
J Womens Health (Larchmt); 2011 May; 20(5):739-47. PubMed ID: 21417935
[TBL] [Abstract][Full Text] [Related]
35. Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act.
Moss HA; Havrilesky LJ; Chino J
Gynecol Oncol; 2017 Sep; 146(3):457-464. PubMed ID: 28641821
[TBL] [Abstract][Full Text] [Related]
36. Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program.
Östensson E; Hellström AC; Hellman K; Gustavsson I; Gyllensten U; Wilander E; Zethraeus N; Andersson S
Acta Obstet Gynecol Scand; 2013 Jul; 92(7):830-40. PubMed ID: 23530870
[TBL] [Abstract][Full Text] [Related]
37. Treatment Costs of Breast Cancer Among Younger Women Aged 19-44 Years Enrolled in Medicaid.
Ekwueme DU; Allaire BT; Guy GP; Arnold S; Trogdon JG
Am J Prev Med; 2016 Feb; 50(2):278-85. PubMed ID: 26775907
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
[TBL] [Abstract][Full Text] [Related]
39. Medicaid enrollment at early stage of disease: the Breast and Cervical Cancer Prevention and Treatment Act in Georgia.
Chien LN; Adams EK; Yang Z
Inquiry; 2011; 48(3):197-208. PubMed ID: 22235545
[TBL] [Abstract][Full Text] [Related]
40. Reimbursed Costs of Management of Uterine Cervical Lesions in Poland--a Descriptive Analysis of Data from the National Health Fund and the Ministry of Health.
Nowakowski A; Śliwczyński A; Seroczyński P; Cybulski M; Teter Z
Cent Eur J Public Health; 2016 Jun; 24(2):163-8. PubMed ID: 27178030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
